Genmab A/S (ADR)

General ticker "GMAB" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $18.0B (TTM average)

Genmab A/S (ADR) follows the US Stock Market performance with the rate: 12.5%.

Estimated limits based on current volatility of 1.7%: low 32.29$, high 33.43$

Factors to consider:

  • Total employees count: 3029 (+12.9%) as of 2025
  • Price in estimated range
  • Earnings for 6 months up through Q2 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [25.50$, 40.98$]
  • 2026-12-31 to 2027-12-31 estimated range: [25.23$, 40.64$]

Financial Metrics affecting the GMAB estimates:

  • Positive: with PPE of 21.1 at the end of fiscal year the price was neutral
  • Positive: 22.58 < Operating profit margin, % of 33.60
  • Positive: 4.90 < Operating cash flow per share per price, % of 5.85
  • Positive: Interest expense per share per price, % of 0.30 <= 0.33
  • Negative: Investing cash flow per share per price, % of -27.82 <= -18.95
  • Positive: Inventory ratio change, % of -0.34 <= 0
  • Negative: negative Industry operating cash flow (median)

Similar symbols

Short-term GMAB quotes

Long-term GMAB plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue DKK16,474.00MM DKK21,526.00MM DKK3,722.93MM
Operating Expenses DKK11,153.00MM DKK14,823.00MM DKK2,471.95MM
Operating Income DKK5,321.00MM DKK6,703.00MM DKK1,250.99MM
Non-Operating Income DKK316.00MM DKK2,461.00MM DKK-46.04MM
Interest Expense DKK27.00MM DKK120.00MM DKK61.05MM
R&D Expense DKK7,630.00MM DKK9,748.00MM DKK1,560.23MM
Income(Loss) DKK5,637.00MM DKK9,164.00MM DKK1,204.95MM
Taxes DKK0.00MM DKK1,320.00MM DKK241.19MM
Net Income(Loss)* DKK4,352.00MM DKK7,844.00MM DKK963.76MM
Stockholders Equity DKK31,610.00MM DKK36,697.00MM DKK5,833.66MM
Inventory DKK57.00MM DKK62.00MM DKK17.96MM
Assets DKK35,289.00MM DKK45,811.00MM DKK12,843.63MM
Operating Cash Flow DKK7,380.00MM DKK7,771.00MM DKK1,186.94MM
Capital expenditure DKK376.00MM DKK187.00MM DKK37.03MM
Investing Cash Flow DKK-1,282.00MM DKK-9,907.00MM DKK-5,647.45MM
Financing Cash Flow DKK-606.00MM DKK-3,919.00MM DKK4,792.78MM
Earnings Per Share** DKK6.60 DKK12.14 DKK1.55
Ordinary share to ADR 1.00x 1.00x 1.00x

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.